Latest news from Athens! All COVID restrictions will be lifted from June 1st Check details here and stay connected Join EGS in Athens !

Коллеги! Добро пожаловать на глобальный хиругический семинар!

iCare DRSplus fundus imaging system with TrueColor Confocal Technology iCare DRSplus confocal fundus imaging system uses white LED illumination to offer high-quality TrueColor images. TrueColor Confocal Technology, which is considered a standard of high image quality, provides detail-rich images with greater image sharpness, optical resolution and contrast when compared to traditional fundus camera imaging.

Program Overview Managing hypotony after trabeculectomy, presented by Vijaya Lingam. Panelists: Vital Costa and Paul Healey. Moderated by Tanuj Dada. Managing hypotony after tubes, presented by Keith Barton. Panelists: Steve Gedde and Anne Coleman. Moderated by Pradeep Ramulu.

«2-й ТЕЛЕМОСТ ЭКСПЕРТОВ-ГЛАУКОМАТОЛОГОВ» Проблемы диспансеризации пациентов с глаукомой, 11 марта 2022 года, с 11-00 до 15-00 часов (МСК-время)

For example, patients with chronic ocular diseases, including glaucoma, age-related macular degeneration and diabetic retinopathy, require frequent administration of therapeutics in the form of either invasive intravitreal injections or eye drops. LADD systems can achieve prolonged therapeutic drug concentrations in target ocular tissues whilst improving patient adherence to therapy and limiting systemic exposure and side effects.

Первая пятница декабря ждет Вас! Там же!

Glaucoma is a chronic and progressive optic nerve neuropathy involving the death of retinal ganglion cells (RGCs). Elevated intraocular pressure (IOP) is considered to be the major risk factor associated with the development of this neuropathy. The objective of the present study was to compare the effects on RGC survival of three different experimental methods to induce chronic elevation of IOP in rats. These methods were: (i) injections of latex microspheres into the eye anterior chamber; (ii) injections into the anterior chamber of a mixture of microspheres plus hydroxypropylmethylcellulose (HPM) and (iii) cauterization of three episcleral veins. The IOP of right (control) and left (glaucomatous) eyes was measured with an applanation tonometer in awake animals. Thirteen to 30 weeks later, RGCs were retrogradely labeled with 3% fluo- rogold. Subsequently, we analyzed the density of RGCs, as well as the major axis length and area of RGC soma resulting from the application of each method. A significant increase in IOP was found following application of each of the three methods. Cell death was evident in the glau- comatous eyes as compared to controls. However, no statistical differences were found between the extent of cell death associated with each of the three methods. IOP increase also induced a significant increase in the size of the soma of the remaining RGCs. In conclusion, the three methods used to increase IOP induce a similar degree of RGC death. Moreover, the extent of cell death was similar when the retinas were main- tained under conditions of elevated IOP for 24 weeks in comparison to 13 weeks.

Three patients with progressive visual loss, chronic alcoholism and tabagism were submitted to a complete neuro-ophthalmic examination and to retinal nerve fiber layer (RNFL) measurements using optical coherence tomography (OCT) scanning. Two patients showed marked RNFL loss in the temporal sector of the optic disc. However, a third patient presented RNFL measurements within or above normal limits, based on the Stratus-OCT normative database. Such findings may be due to possible RNFL edema similar to the one that may occur in the acute phase of toxic optic neuropathies. Stratus-OCT was able to detect RNFL loss in the papillomacular bundle of patients with tobacco-alcohol-induced toxic optic neuropathy. However, interpretation must be careful when OCT does not show abnormality in order to prevent diagnostic confusion, since overestimation of RNFL thickness measurements is possible in such cases.

Скоро! Активно ищем в сети!

Более 500 страниц очень "правильной" информации для тех, кто следит за хирургией глаукомы

Новый проект Российского глаукомного общества и группы молодых ученых Научный авангард,

Уважаемые коллеги! Приглашаем вас на Всероссийскую научно-практическую конференцию с международным участием «Фёдоровские чтения»! Она пройдет в режиме онлайн 7−8 июня 2022 года. Мероприятие является стартовой площадкой для молодых специалистов-офтальмологов. Этим летом Святославу Фёдорову могло бы исполниться 95 лет. Великий учёный-офтальмолог придавал особое значение поддержке молодых талантливых врачей, поэтому проведение «Фёдоровских чтений» будет знаковым событием юбилейного 2022 года.

Авангард. Новое мероприятие. Дебаты! Открыто для всех!

22 февраля 2022 г. в рамках 30-й Московской международной оптической выставки MIOF пройдет VIII Церемония награждения победителей Национальной премии оптической индустрии «Золотой лорнет»

Подробные подробности и от мировых лидеров офтальмологии!

Achieving a quick and correct diagnosis of neuromyelitis optica spectrum disorder (NMOSD) remains challenging, even after the discovery of disease-specific autoantibodies to aquaporin-4. Salient symptoms of NMOSD are non-specific, and some clinicians have confused the condition with multiple sclerosis or other disorders. Until recently, treatments to manage acute attacks and prevent future episodes were limited to off-label options like azathioprine, mycophenolate, and rituximab. However, within the last 2 years, the therapeutic landscape has widened significantly with FDA approval of eculizumab, inebilizumab, and satralizumab. To improve patient outcomes, neurologists would benefit from continuing education that keeps them up to date on treatment advances and best practices for making a timely, accurate NMOSD diagnosis.

Дорогие друзья, приглашаем вас принять участие во ВСЕРОССИЙСКОЙ ШКОЛЕ БИОМЕТРИИ, которая пройдет 21 СЕНТЯБРЯ в рамках РООФ-2021 Место проведения: Конференц-зал НМИЦ глазных болезней им. Гельмгольца адрес: 105062, Москва, ул. Садовая-Черногрязская 14/19, ст. метро «Красные ворота»

c 1 августа (для самых нетерпеливых) - на сайте www.GlaucomaNews.ru и в социальных сетях Общества

Glaucoma is a progressive optic neuropathy and is the leading cause of irreversible blindness worldwide. Over 60 million people were estimated to be affected with open-angle glaucoma (OAG) in 2010, and bilateral blindness from the disease was estimated to be present in 4.5 million people with OAG in 2010, rising to 5.9 million people in 2020